Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

HB998: Menstrual products ingredient labeling; restriction of substances, delayed effective date.

signed by governor

<b>Menstrual supplies ingredient labeling; restriction of substances; civil penalty.</b> Requires that each package or box containing menstrual supplies, as defined in the bill, contain a label of all ingredients that are included within such products when sold within the Commonwealth. Such label shall be displayed by the manufacturer in a manner that is visible and easy to understand for the consumer. The bill requires any manufacturer to make changes to the label reflecting any changes of ingredients within 18 months of any such changes. The bill also requires the manufacturer to post the required label information on its website. The bill has a delayed effective date of January 1, 2027.

Official bill page · Source: Richmond Sunlight

Ask about HB998

Full bill text

Version CHAP0249 · 2026-04-06

Full text

Changes in this version: added text deleted text

An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1, relating to menstrual products ingredient labeling; civil penalty.

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1 as follows:

§ 32.1-73.28:1. Menstrual products ingredient labeling; civil penalty.

A. As used in this section:

"Confidential substance" means any element or substance that a manufacturer has added to a menstrual product that serves a technical or functional purpose in the finished menstrual product and:

1. For which a claim has been approved by the U.S. Environmental Protection Agency for inclusion on the confidential portion of the Toxic Substances Control Act Chemical Substance Inventory, established pursuant to 15 U.S.C. § 2607(b) and 40 C.F.R. Part 710;

2. For which the manufacturer of the menstrual products or the supplier of the substance claims protection under the federal Defend Trade Secrets Act of 2016 (18 U.S.C. § 1836 et seq.); or

3. That is generally recognized as safe by the U.S. Food and Drug Administration pursuant to 21 C.F.R. § 170.30.

"Ingredient" means any intentionally added substance present in a menstrual product that serves a technical or functional purpose in the finished product, provided that the substance or the combination of substances is not considered a confidential substance.

"Label" means a display of written, printed, or graphic material on or affixed to a container in which the menstrual products are distributed.

"Menstrual product" means a disposable or reusable product manufactured for the purpose of catching menstruation and vaginal discharge, including a tampon, sanitary pad, disc, menstrual cup, and menstrual underwear.

"Package or box containing menstrual products" does not include packaging used exclusively for shipping purposes.

B. Each package or box containing menstrual products manufactured for sale or distribution within the Commonwealth shall contain a label of all ingredients that are included within such menstrual products, with such ingredients listed in descending order of predominance. The label shall be displayed by the manufacturer in a manner that is visible and easy for the consumer to understand. A manufacturer that changes, adds, or removes an ingredient of a menstrual product shall make changes to the label required pursuant to this subsection reflecting such change, addition, or removal within 18 months of such change, addition, or removal. The provisions of this subsection shall not restrict the continued sale of menstrual products manufactured before January 1, 2027.

C. A manufacturer of menstrual products shall post on its website (i) the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B and (ii) information regarding any change to the label on a menstrual product required pursuant to subsection B after changing, adding, or removing an ingredient within six months of such change, addition, or removal. The manufacturer may use technologies, including a digital link, to communicate information pursuant to this section.

D. No manufacturer of menstrual products sold within the Commonwealth shall be required under this section to disclose a confidential substance on a package or box or on its website. If a manufacturer declines to disclose a confidential substance on a package or box containing menstrual products or on its website in order to protect the identity of such confidential substance, such manufacturer shall include such confidential substance by its common name with the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B.

E. Any violation of this section shall constitute a prohibited practice under § 59.1-200 and shall be subject to the enforcement provisions of the Virginia Consumer Protection Act (§ 59.1-196 et seq.).

2. That the provisions of this act shall become effective on January 1, 2027.

Legislative actions

2026-03-11 · history

Fiscal Impact Statement from Department of Planning and Budget (HB998)

2026-04-06 · history

Approved by Governor - Chapter 249 (effective 1/1/2027)

2026-02-17 · history

Read third time and passed House (69-Y 28-N 0-A)

2026-03-02 · history

Education and Health Amendment agreed to

2026-02-27 · history

Passed by for the day Block Vote (Voice Vote)

2026-03-11 · history

Enrolled

2026-02-16 · history

Engrossed by House - committee substitute

2026-02-10 · history

Subcommittee recommends reporting with substitute (6-Y 3-N)

2026-02-16 · history

Read second time

2026-01-23 · history

Assigned sub: Health

2026-02-12 · history

House committee offered

2026-02-06 · history

Fiscal Impact Statement from Department of Planning and Budget (HB998)

2026-04-06 · history

Acts of Assembly Chapter text (CHAP0249)

2026-02-12 · history

Committee substitute printed 26107800D-H1

2026-03-04 · history

Senate amendment agreed to by House (69-Y 25-N 0-A)

2026-02-12 · history

Reported from Health and Human Services with substitute (16-Y 5-N)

2026-02-26 · history

Reported from Education and Health with amendment (9-Y 3-N)

2026-01-14 · history

Prefiled and ordered printed; Offered 01-14-2026 26104843D

2026-03-02 · history

Passed Senate with amendment (24-Y 16-N 0-A)

2026-02-27 · history

Passed by for the day

2026-01-14 · history

Referred to Committee on Health and Human Services

2026-02-24 · history

Senate committee offered

2026-02-18 · history

Referred to Committee on Education and Health

2026-02-15 · history

Read first time

2026-02-18 · history

Constitutional reading dispensed (on 1st reading)

2026-03-02 · history

Engrossed by Senate as amended

2026-02-26 · history

Reported from Education and Health with amendment

2026-02-23 · history

Fiscal Impact Statement from Department of Planning and Budget (HB998)

2026-02-10 · history

House subcommittee offered

2026-02-27 · history

Constitutional reading dispensed Block Vote (on 2nd reading) (37-Y 0-N 0-A)

2026-02-27 · history

Rules suspended

2026-03-02 · history

Read third time

2026-02-10 · history

Subcommittee recommends reporting with substitute

2026-03-14 · history

Enrolled Bill communicated to Governor on March 14, 2026

2026-03-12 · history

Signed by Speaker

2026-04-06 · history

Approved by Governor-Chapter 249 (effective 7/1/2026)

2026-03-02 · history

Committee amendment agreed to (Voice Vote)

2026-03-11 · history

Signed by President

2026-02-12 · history

Reported from Health and Human Services with substitute

2026-02-16 · history

committee substitute agreed to

2026-03-11 · history

Bill text as passed House and Senate (HB998ER)

2026-03-14 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

Raw source record
{
    "id": 84847,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb998\/",
    "tags": {
        "149575": "women's health",
        "149576": "labeling",
        "149577": "safety",
        "149578": "regulation",
        "149579": "consumer protection",
        "149580": "penalty"
    },
    "text": [
        {
            "date": "2026-01-14",
            "number": "HB998",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb998.pdf"
        },
        {
            "date": "2026-02-12",
            "number": "HB998H1"
        },
        {
            "date": "2026-03-11",
            "number": "HB998ER"
        },
        {
            "date": "2026-04-06",
            "number": "CHAP0249"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "hb998",
    "patron": "Seibold, Holly",
    "status": "signed by governor",
    "chamber": "house",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 84122,
            "name": "Agriculture, Chesapeake and Natural Resources",
            "year": 2026,
            "count": 4,
            "number": "hb322",
            "status": "signed by governor",
            "catch_line": "Misbranded food; manufactured-protein food products, civil penalty.",
            "date_introduced": "January 11, 2026"
        },
        {
            "id": 84076,
            "name": "Agriculture, Conservation and Natural Resources",
            "year": 2026,
            "count": 4,
            "number": "sb186",
            "status": "signed by governor",
            "catch_line": "Misbranded food; manufactured-protein food products, civil penalty.",
            "date_introduced": "January 09, 2026"
        },
        {
            "id": 84575,
            "name": "General Laws",
            "year": 2026,
            "count": 3,
            "number": "hb738",
            "status": "failed committee",
            "catch_line": "Virginia Consumer Protection Act; prohibited practices, kratom products.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 85485,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "sb486",
            "status": "failed committee",
            "catch_line": "Gluten disclaimer; required disclosures for dietary supplements and medication.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 83768,
            "name": "Militia, Police and Public Safety",
            "year": 2026,
            "count": 3,
            "number": "hb110",
            "status": "signed by governor",
            "catch_line": "Handguns in unattended motor vehicle; definitions, penalty.",
            "date_introduced": "January 02, 2026"
        }
    ],
    "summary": "<b>Menstrual supplies ingredient labeling; restriction of substances; civil penalty.<\/b> Requires that each package or box containing menstrual supplies, as defined in the bill, contain a label of all ingredients that are included within such products when sold within the Commonwealth. Such label shall be displayed by the manufacturer in a manner that is visible and easy to understand for the consumer. The bill requires any manufacturer to make changes to the label reflecting any changes of ingredients within 18 months of any such changes. The bill also requires the manufacturer to post the required label information on its website. The bill has a delayed effective date of January 1, 2027.",
    "version": "CHAP0249",
    "copatron": [
        {
            "shortname": "rccousins",
            "partisanship": 16,
            "name_formatted": "Del. Rae Cousins (D-Richmond)"
        },
        {
            "shortname": "kkltran",
            "partisanship": 17,
            "name_formatted": "Del. Kathy Tran (D-Springfield)"
        }
    ],
    "committee": null,
    "full_text": "<p class=\"ldtitle\">An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.28:1\/'>32.1-73.28:1<\/a>, relating to menstrual products ingredient labeling; civil penalty.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That the Code of Virginia is amended by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.28:1\/'>32.1-73.28:1<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.28:1\/'>32.1-73.28:1<\/a>. Menstrual products ingredient labeling; civil penalty.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. As used in this section:<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Confidential substance\" means any element or substance that a manufacturer has added to a menstrual product that serves a technical or functional purpose in the finished menstrual product and:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. For which a claim has been approved by the U.S. Environmental Protection Agency for inclusion on the confidential portion of the Toxic Substances Control Act Chemical Substance Inventory, established pursuant to 15 U.S.C. \u00a7 2607(b) and 40 C.F.R. Part 710;<\/ins><\/p><p class=\"section\"><em class=\"new\">2. For which the manufacturer of the menstrual products or the supplier of the substance claims protection under the federal Defend Trade Secrets Act of 2016 (18 U.S.C. \u00a7 1836 et seq.); or<\/ins><\/p><p class=\"section\"><em class=\"new\">3. That is generally recognized as safe by the U.S. Food and Drug Administration pursuant to 21 C.F.R. \u00a7 170.30.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Ingredient\" means any intentionally added substance present in a menstrual product that serves a technical or functional purpose in the finished product, provided that the substance or the combination of substances is not considered a confidential substance.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Label\" means a display of written, printed, or graphic material on or affixed to a container in which the menstrual products are distributed.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Menstrual product\" means a disposable or reusable product manufactured for the purpose of catching menstruation and vaginal discharge, including a tampon, sanitary pad, disc, menstrual cup, and menstrual underwear.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Package or box containing menstrual products\" does not include packaging used exclusively for shipping purposes.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. Each package or box containing menstrual products manufactured for sale or distribution within the Commonwealth shall contain a label of all ingredients that are included within such menstrual products, with such ingredients listed in descending order of predominance. The label shall be displayed by the manufacturer in a manner that is visible and easy for the consumer to understand. A manufacturer that changes, adds, or removes an ingredient of a menstrual product shall make changes to the label required pursuant to this subsection reflecting such change, addition, or removal within 18 months of such change, addition, or removal. The provisions of this subsection shall not restrict the continued sale of menstrual products manufactured before January 1, 2027.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. A manufacturer of menstrual products shall post on its website (i) the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B and (ii) information regarding any change to the label on a menstrual product required pursuant to subsection B after changing, adding, or removing an ingredient within six months of such change, addition, or removal. The manufacturer may use technologies, including a digital link, to communicate information pursuant to this section.<\/ins><\/p><p class=\"section\"><em class=\"new\">D. No manufacturer of menstrual products sold within the Commonwealth shall be required under this section to disclose a confidential substance on a package or box or on its website. If a manufacturer declines to disclose a confidential substance on a package or box containing menstrual products or on its website in order to protect the identity of such confidential substance, such manufacturer shall include such confidential substance by its common name with the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B.<\/ins><\/p><p class=\"section\"><em class=\"new\">E. <em>Any violation of this section shall constitute a prohibited practice under \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/59.1-200\/'>59.1-200<\/a> and shall be subject to the enforcement provisions of the Virginia Consumer Protection Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/59.1-196\/'>59.1-196<\/a> et seq.).<\/ins><\/ins><\/p><p class=\"enactcls\">2. That the provisions of this act shall become effective on January 1, 2027.<\/p>",
    "catch_line": "Menstrual products ingredient labeling; restriction of substances, delayed effective date.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 808,
    "patron_party": "D",
    "patron_place": "Vienna",
    "summary_hash": "7324c095bf57a72973b384f887365173",
    "patron_prefix": "Del.",
    "patron_suffix": "(D-Vienna)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "f9e9bd8772aba559cd6437982cbedfa40ea6ecf661aec8d25a735db13b7d2e1b",
            "code": "CHAP0249",
            "bill_id": 84847,
            "source_url": null,
            "source_date": "2026-04-06",
            "source_hash": "116c82c29d474dd10d3c6e716bb7459ab8a553d79a5a1e7e90f3685ed23d26e2",
            "source_html": "<p class=\"ldtitle\">An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.28:1\/'>32.1-73.28:1<\/a>, relating to menstrual products ingredient labeling; civil penalty.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That the Code of Virginia is amended by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.28:1\/'>32.1-73.28:1<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.28:1\/'>32.1-73.28:1<\/a>. Menstrual products ingredient labeling; civil penalty.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. As used in this section:<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Confidential substance\" means any element or substance that a manufacturer has added to a menstrual product that serves a technical or functional purpose in the finished menstrual product and:<\/ins><\/p><p class=\"section\"><em class=\"new\">1. For which a claim has been approved by the U.S. Environmental Protection Agency for inclusion on the confidential portion of the Toxic Substances Control Act Chemical Substance Inventory, established pursuant to 15 U.S.C. \u00a7 2607(b) and 40 C.F.R. Part 710;<\/ins><\/p><p class=\"section\"><em class=\"new\">2. For which the manufacturer of the menstrual products or the supplier of the substance claims protection under the federal Defend Trade Secrets Act of 2016 (18 U.S.C. \u00a7 1836 et seq.); or<\/ins><\/p><p class=\"section\"><em class=\"new\">3. That is generally recognized as safe by the U.S. Food and Drug Administration pursuant to 21 C.F.R. \u00a7 170.30.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Ingredient\" means any intentionally added substance present in a menstrual product that serves a technical or functional purpose in the finished product, provided that the substance or the combination of substances is not considered a confidential substance.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Label\" means a display of written, printed, or graphic material on or affixed to a container in which the menstrual products are distributed.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Menstrual product\" means a disposable or reusable product manufactured for the purpose of catching menstruation and vaginal discharge, including a tampon, sanitary pad, disc, menstrual cup, and menstrual underwear.<\/ins><\/p><p class=\"section\"><em class=\"new\">\"Package or box containing menstrual products\" does not include packaging used exclusively for shipping purposes.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. Each package or box containing menstrual products manufactured for sale or distribution within the Commonwealth shall contain a label of all ingredients that are included within such menstrual products, with such ingredients listed in descending order of predominance. The label shall be displayed by the manufacturer in a manner that is visible and easy for the consumer to understand. A manufacturer that changes, adds, or removes an ingredient of a menstrual product shall make changes to the label required pursuant to this subsection reflecting such change, addition, or removal within 18 months of such change, addition, or removal. The provisions of this subsection shall not restrict the continued sale of menstrual products manufactured before January 1, 2027.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. A manufacturer of menstrual products shall post on its website (i) the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B and (ii) information regarding any change to the label on a menstrual product required pursuant to subsection B after changing, adding, or removing an ingredient within six months of such change, addition, or removal. The manufacturer may use technologies, including a digital link, to communicate information pursuant to this section.<\/ins><\/p><p class=\"section\"><em class=\"new\">D. No manufacturer of menstrual products sold within the Commonwealth shall be required under this section to disclose a confidential substance on a package or box or on its website. If a manufacturer declines to disclose a confidential substance on a package or box containing menstrual products or on its website in order to protect the identity of such confidential substance, such manufacturer shall include such confidential substance by its common name with the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B.<\/ins><\/p><p class=\"section\"><em class=\"new\">E. <em>Any violation of this section shall constitute a prohibited practice under \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/59.1-200\/'>59.1-200<\/a> and shall be subject to the enforcement provisions of the Virginia Consumer Protection Act (\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/59.1-196\/'>59.1-196<\/a> et seq.).<\/ins><\/ins><\/p><p class=\"enactcls\">2. That the provisions of this act shall become effective on January 1, 2027.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-04-06",
                    "number": "CHAP0249"
                }
            }
        }
    ],
    "copatron_count": 2,
    "patron_address": [
        "P.O. Box 2304",
        "Vienna",
        "VA 22183"
    ],
    "patron_chamber": "house",
    "patron_started": 2023,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "04\/06\/2026",
            "status": "Approved by Governor - Chapter 249 (effective 1\/1\/2027)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "04\/06\/2026",
            "status": "Acts of Assembly Chapter text (CHAP0249)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/06\/2026",
            "status": "Approved by Governor-Chapter 249 (effective 7\/1\/2026)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "03\/14\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/14\/2026",
            "status": "Enrolled Bill communicated to Governor on March 14, 2026",
            "date_raw": "2026-03-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/11\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB998)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Bill text as passed House and Senate (HB998ER)",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/11\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-11",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Senate amendment agreed to by House (69-Y 25-N 0-A)",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": "300561",
            "translation": null
        },
        {
            "date": "03\/02\/2026",
            "status": "Education and Health Amendment agreed to",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": "299908",
            "translation": null
        },
        {
            "date": "03\/02\/2026",
            "status": "Engrossed by Senate as amended",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/02\/2026",
            "status": "Passed Senate with amendment (24-Y 16-N 0-A)",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": "299909",
            "translation": "passed senate"
        },
        {
            "date": "03\/02\/2026",
            "status": "Committee amendment agreed to (Voice Vote)",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": "299908",
            "translation": null
        },
        {
            "date": "03\/02\/2026",
            "status": "Read third time",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": "299599",
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 2nd reading) (37-Y 0-N 0-A)",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": "299598",
            "translation": null
        },
        {
            "date": "02\/27\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-02-27",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/26\/2026",
            "status": "Reported from Education and Health with amendment (9-Y 3-N)",
            "date_raw": "2026-02-26",
            "vote_count": null,
            "lis_vote_id": "299111",
            "translation": "passed committee"
        },
        {
            "date": "02\/26\/2026",
            "status": "Reported from Education and Health with amendment",
            "date_raw": "2026-02-26",
            "vote_count": null,
            "lis_vote_id": "299111",
            "translation": "passed committee"
        },
        {
            "date": "02\/24\/2026",
            "status": "Senate committee offered",
            "date_raw": "2026-02-24",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/23\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB998)",
            "date_raw": "2026-02-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/18\/2026",
            "status": "Referred to Committee on Education and Health",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/18\/2026",
            "status": "Constitutional reading dispensed (on 1st reading)",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/17\/2026",
            "status": "Read third time and passed House (69-Y 28-N 0-A)",
            "date_raw": "2026-02-17",
            "vote_count": null,
            "lis_vote_id": "297879",
            "translation": "passed house"
        },
        {
            "date": "02\/16\/2026",
            "status": "Engrossed by House - committee substitute",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "committee substitute agreed to",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/15\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-15",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Committee substitute printed 26107800D-H1",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Reported from Health and Human Services with substitute (16-Y 5-N)",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": "296735",
            "translation": "passed committee"
        },
        {
            "date": "02\/12\/2026",
            "status": "House committee offered",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/12\/2026",
            "status": "Reported from Health and Human Services with substitute",
            "date_raw": "2026-02-12",
            "vote_count": null,
            "lis_vote_id": "296735",
            "translation": "passed committee"
        },
        {
            "date": "02\/10\/2026",
            "status": "Subcommittee recommends reporting with substitute (6-Y 3-N)",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": "296066",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/10\/2026",
            "status": "Subcommittee recommends reporting with substitute",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/10\/2026",
            "status": "House subcommittee offered",
            "date_raw": "2026-02-10",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/06\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB998)",
            "date_raw": "2026-02-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/23\/2026",
            "status": "Assigned sub: Health",
            "date_raw": "2026-01-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/14\/2026",
            "status": "Referred to Committee on Health and Human Services",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/14\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26104843D",
            "date_raw": "2026-01-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 492,
    "date_introduced": "2026-01-14",
    "patron_district": 12,
    "patron_shortname": "hmseibold",
    "committee_chamber": null,
    "status_detail_date": "04\/06\/2026",
    "committee_shortname": null,
    "patron_name_formatted": "Del. Holly Seibold (D-Vienna)"
}